8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2024

Overview

Journal Diabetes Care

Specialty Endocrinology

Date 2023 Dec 11

PMID 38078578

Affiliations

Soon will be listed here.

Abstract

The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, an interprofessional expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

Citing Articles

Body Fat and Visceral Fat Values in Spanish Healthcare Workers: Associated Variables.

Tarraga Marcos P, Lopez-Gonzalez A, Martinez-Almoyna Rifa E, Paublini Oliveira H, Martorell Sanchez C, Tarraga Lopez P Nutrients. 2025; 17(4).

PMID: 40004977 PMC: 11858298. DOI: 10.3390/nu17040649.

Type 2 diabetes: a sacrifice program handling energy surplus.

Ye J, Yin J Life Metab. 2025; 3(6):loae033.

PMID: 39873003 PMC: 11748514. DOI: 10.1093/lifemeta/loae033.

Characteristics and Dosing Patterns of Tirzepatide Users with Type 2 Diabetes in the United States.

Mody R, Desai K, Teng C, Reznor G, Stockbower G, Grabner M Diabetes Ther. 2025; 16(2):307-327.

PMID: 39794609 PMC: 11794899. DOI: 10.1007/s13300-024-01684-6.

Effectiveness of Dietitian-Involved Lifestyle Interventions in Diabetes Management Among Arab Populations: A Systematic Review and Meta-Analysis.

Sheffer-Hilel G, Abd Elqader O, Suliman L, Srulovici E Nutrients. 2025; 16(24).

PMID: 39770905 PMC: 11678749. DOI: 10.3390/nu16244283.

Effects of Semaglutide and Tirzepatide on Bone Metabolism in Type 2 Diabetic Mice.

Lv F, Cai X, Lin C, Yang W, Ji L Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770498 PMC: 11728704. DOI: 10.3390/ph17121655.

References

Billeter A, Scheurlen K, Probst P, Eichel S, Nickel F, Kopf S . Meta-analysis of metabolic surgery versus medical treatment for microvascular complications in patients with type 2 diabetes mellitus. Br J Surg. 2018; 105(3):168-181. DOI: 10.1002/bjs.10724. View

Aggarwal R, Bibbins-Domingo K, Yeh R, Song Y, Chiu N, Wadhera R . Diabetes Screening by Race and Ethnicity in the United States: Equivalent Body Mass Index and Age Thresholds. Ann Intern Med. 2022; 175(6):765-773. DOI: 10.7326/M20-8079. View

Bosch X, Monclus E, Escoda O, Guerra-Garcia M, Moreno P, Guasch N . Unintentional weight loss: Clinical characteristics and outcomes in a prospective cohort of 2677 patients. PLoS One. 2017; 12(4):e0175125. PMC: 5384681. DOI: 10.1371/journal.pone.0175125. View

. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403):157-63. DOI: 10.1016/S0140-6736(03)15268-3. View

Garvey W, Frias J, Jastreboff A, le Roux C, Sattar N, Aizenberg D . Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2023; 402(10402):613-626. DOI: 10.1016/S0140-6736(23)01200-X. View

Sjostrom L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden A . Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014; 311(22):2297-304. DOI: 10.1001/jama.2014.5988. View

Frias J, Davies M, Rosenstock J, Perez Manghi F, Lando L, Bergman B . Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021; 385(6):503-515. DOI: 10.1056/NEJMoa2107519. View

Altieri M, Yang J, Telem D, Meng Z, Frenkel C, Halbert C . Lap band outcomes from 19,221 patients across centers and over a decade within the state of New York. Surg Endosc. 2015; 30(5):1725-32. DOI: 10.1007/s00464-015-4402-8. View

Peterhansel C, Petroff D, Klinitzke G, Kersting A, Wagner B . Risk of completed suicide after bariatric surgery: a systematic review. Obes Rev. 2013; 14(5):369-82. DOI: 10.1111/obr.12014. View

10.

Conason A, Teixeira J, Hsu C, Puma L, Knafo D, Geliebter A . Substance use following bariatric weight loss surgery. JAMA Surg. 2013; 148(2):145-50. DOI: 10.1001/2013.jamasurg.265. View

11.

Hollander P, Elbein S, Hirsch I, Kelley D, McGill J, Taylor T . Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes Care. 1998; 21(8):1288-94. DOI: 10.2337/diacare.21.8.1288. View

12.

Eisenberg D, Shikora S, Aarts E, Aminian A, Angrisani L, Cohen R . 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis. 2022; 18(12):1345-1356. DOI: 10.1016/j.soard.2022.08.013. View

13.

Yu H, Di J, Bao Y, Zhang P, Zhang L, Tu Y . Visceral fat area as a new predictor of short-term diabetes remission after Roux-en-Y gastric bypass surgery in Chinese patients with a body mass index less than 35 kg/m2. Surg Obes Relat Dis. 2014; 11(1):6-11. DOI: 10.1016/j.soard.2014.06.019. View

14.

Gadde K, Allison D, Ryan D, Peterson C, Troupin B, Schwiers M . Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet. 2011; 377(9774):1341-52. DOI: 10.1016/S0140-6736(11)60205-5. View

15.

Rubin J, Hinrichs-Krapels S, Hesketh R, Martin A, Herman W, Rubino F . Identifying Barriers to Appropriate Use of Metabolic/Bariatric Surgery for Type 2 Diabetes Treatment: Policy Lab Results. Diabetes Care. 2016; 39(6):954-63. PMC: 5864132. DOI: 10.2337/dc15-2781. View

16.

Fujioka K, Plodkowski R, ONeil P, Gilder K, Walsh B, Greenway F . The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapy. Int J Obes (Lond). 2016; 40(9):1369-75. DOI: 10.1038/ijo.2016.67. View

17.

Kirwan J, Aminian A, Kashyap S, Burguera B, Brethauer S, Schauer P . Bariatric Surgery in Obese Patients With Type 1 Diabetes. Diabetes Care. 2016; 39(6):941-8. PMC: 8310563. DOI: 10.2337/dc15-2732. View

18.

Saris W . Very-low-calorie diets and sustained weight loss. Obes Res. 2001; 9 Suppl 4:295S-301S. DOI: 10.1038/oby.2001.134. View

19.

Aminian A, Kashyap S, Wolski K, Brethauer S, Kirwan J, Nissen S . Patient-reported Outcomes After Metabolic Surgery Versus Medical Therapy for Diabetes: Insights From the STAMPEDE Randomized Trial. Ann Surg. 2021; 274(3):524-532. PMC: 8373787. DOI: 10.1097/SLA.0000000000005003. View

20.

Jakobsen G, Smastuen M, Sandbu R, Nordstrand N, Hofso D, Lindberg M . Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities. JAMA. 2018; 319(3):291-301. PMC: 5833560. DOI: 10.1001/jama.2017.21055. View